Supreme Court weighs generic drug dispute

The Supreme Court seems divided as it considers a high-stakes patent dispute between rival pharmaceutical companies over the world’s best-selling multiple sclerosis treatment. Justices heard arguments Wednesday in a case that threatens to cut into the profits of...